Standout Papers

Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA ... 2018 2026 2020 2023 262
  1. Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study (2018)
    Suresh S. Ramalingam, Yi Cheng et al. Annals of Oncology

Immediate Impact

1 from Science/Nature 70 standout
Sub-graph 1 of 21

Citing Papers

Lung cancer statistics, 2023
2024 Standout
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
2 intermediate papers

Works of A. Todd being referenced

OA07.01 Osimertinib Plus Platinum/Pemetrexed in Newly-Diagnosed Advanced EGFRm-Positive NSCLC; The Phase 3 FLAURA2 Study
2019
Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study
2018 Standout

Author Peers

Author Last Decade Papers Cites
A. Todd 314 246 4 120 8 332
Y. Ohe 281 234 3 119 12 317
J.C.-H. Yang 277 260 7 91 12 345
Barbara Collins 216 143 8 105 10 306
Li Xu 224 216 8 122 11 340
Corinne Clifford 212 199 15 90 14 345
Janice J.N. Li 211 171 5 109 16 317
Laura Emerson 283 243 8 87 5 348
Diana Gernhardt 191 243 13 132 8 327
Mark D. Kochenderfer 192 224 24 140 14 350
Seiji Kosaihira 227 175 9 159 15 366

All Works

Loading papers...

Rankless by CCL
2026